Aktis Oncology, Inc. (AKTS)
Pharmaceutical Preparations
Latest Price
$22.07
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
10.41
P/B Ratio
2.12
Institutional Ownership
64.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 4.84M | $86.0M | 9.06% | -- | 2026-03-31 |
| EcoR1 Capital, LLC | 4.82M | $86.0M | 9.03% | -- | 2026-03-31 |
| Blue Owl Capital Holdings LP | 3.16M | $56.0M | 5.92% | -- | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.32M | $41.0M | 4.34% | -- | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 2.12M | $37.0M | 3.98% | -- | 2026-03-31 |
| BlackRock, Inc. | 2.11M | $37.0M | 3.96% | -- | 2026-03-31 |
| RTW INVESTMENTS, LP | 1.59M | $28.0M | 2.98% | -- | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.56M | $27.0M | 2.93% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1.50M | $26.0M | 2.81% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 1.45M | $26.0M | 2.72% | -- | 2026-03-31 |